Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Birgitta Gleeson

Biographic Data

ID9067409
NAMEBirgitta Gleeson
GIVEN NAMESBirgitta
FAMILY NAMEGleeson
SIGNATUREGLEESON B
AFFILIATIONSFIND
ORCID0009-0003-0791-7735
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Aligning neonatal sepsis triage diagnostics with WHO target product profiles in low- and middle-income countries

    Open Access•Birgitta Gleeson, Benjamin Blumel et al.•ARTICLE•BMJ Global Health•2026

    Neonatal sepsis is a leading cause of infant morbidity and mortality in low- and middle-income countries (LMICs), yet despite this, progress in the development and implementation of effective diagnostics has been limited. Current diagnostic methods rely on clinical assessments of nonspecific signs and symptoms, limited laboratory testing and technologies that are inaccessible, unaffordable or unsuitable for resource-constrained settings. There is…

  • Rapid bacterial identification and resistance detection using a low complexity molecular diagnostic platform in Zimbabwe

    Open Access•Tinashe Mwaturura, Ioana D Olaru et al.•ARTICLE•PLOS Global Public Health•2025

    BACKGROUND: Sepsis is a major cause of mortality in low-resource settings. Effective microbiological culture services are a bottleneck in diagnosis and surveillance. AIM: We aimed to evaluate the performance of the BIOFIRE FILMARRAY Blood Culture Identification 2 (BCID2, bioMérieux) assay in a low-resource setting laboratory in comparison to standard practice. METHODS: This five month prospective validation study included all positive blood cultu…

  • Evaluation of a novel point-of-care lateral flow assay screening for Neisseria gonorrhoeae infection among pregnant women in Zimbabwe

    Open Access•Kevin Martín, Ethel Dauya et al.•ARTICLE•PLOS Global Public Health•2025

    Affordable, easy-to-use and rapid diagnostics may support a move away from syndromic management for sexually transmitted infections (STIs) in resource-constrained settings. A lateral flow assay for Neisseria gonorrhoeae (NG-LFA) has shown high sensitivity and specificity (>90%) in symptomatic individuals. We investigated the performance and acceptability of this assay as a screening tool for NG among pregnant women. This evaluation was embedded w…

  • A call to bridge the diagnostic gap

    Open Access•Birgitta Gleeson, Cecilia Ferreyra et al.•ARTICLE•BMJ Global Health•2024

    BOX Low- and middle-income countries (LMICs) bear the greatest burden of neonatal mortality, with sepsis being a major contributor

  • Diagnostic tests to mitigate the antimicrobial resistance pandemic—Still the problem child

    Open Access•Cecilia Ferreyra, Birgitta Gleeson et al.•ARTICLE•PLOS Global Public Health•2022

    The UK Government's 2015 Antimicrobial Resistance (AMR) Review Seven years on, this remains purely aspirational, and diagnostics continue to be the problem child of the AMR pandemic. COVID-19 has demonstrated just how far we still are from such a goal; despite rapid diagnostics for COVID-19 being developed within months of identification of SARS-CoV-2, the virus was able to drive global, large-scale inappropriate antibiotic prescribing for unsubs…

No prominent works on this page.

  • Diagnostic tests to mitigate the antimicrobial resistance pandemic—Still the problem child

    Open Access•Cecilia Ferreyra, Birgitta Gleeson et al.•ARTICLE•PLOS Global Public Health•2022

    The UK Government's 2015 Antimicrobial Resistance (AMR) Review Seven years on, this remains purely aspirational, and diagnostics continue to be the problem child of the AMR pandemic. COVID-19 has demonstrated just how far we still are from such a goal; despite rapid diagnostics for COVID-19 being developed within months of identification of SARS-CoV-2, the virus was able to drive global, large-scale inappropriate antibiotic prescribing for unsubs…

  • A call to bridge the diagnostic gap

    Open Access•Birgitta Gleeson, Cecilia Ferreyra et al.•ARTICLE•BMJ Global Health•2024

    BOX Low- and middle-income countries (LMICs) bear the greatest burden of neonatal mortality, with sepsis being a major contributor

  • Rapid bacterial identification and resistance detection using a low complexity molecular diagnostic platform in Zimbabwe

    Open Access•Tinashe Mwaturura, Ioana D Olaru et al.•ARTICLE•PLOS Global Public Health•2025

    BACKGROUND: Sepsis is a major cause of mortality in low-resource settings. Effective microbiological culture services are a bottleneck in diagnosis and surveillance. AIM: We aimed to evaluate the performance of the BIOFIRE FILMARRAY Blood Culture Identification 2 (BCID2, bioMérieux) assay in a low-resource setting laboratory in comparison to standard practice. METHODS: This five month prospective validation study included all positive blood cultu…

  • Evaluation of a novel point-of-care lateral flow assay screening for Neisseria gonorrhoeae infection among pregnant women in Zimbabwe

    Open Access•Kevin Martín, Ethel Dauya et al.•ARTICLE•PLOS Global Public Health•2025

    Affordable, easy-to-use and rapid diagnostics may support a move away from syndromic management for sexually transmitted infections (STIs) in resource-constrained settings. A lateral flow assay for Neisseria gonorrhoeae (NG-LFA) has shown high sensitivity and specificity (>90%) in symptomatic individuals. We investigated the performance and acceptability of this assay as a screening tool for NG among pregnant women. This evaluation was embedded w…

  • Aligning neonatal sepsis triage diagnostics with WHO target product profiles in low- and middle-income countries

    Open Access•Birgitta Gleeson, Benjamin Blumel et al.•ARTICLE•BMJ Global Health•2026

    Neonatal sepsis is a leading cause of infant morbidity and mortality in low- and middle-income countries (LMICs), yet despite this, progress in the development and implementation of effective diagnostics has been limited. Current diagnostic methods rely on clinical assessments of nonspecific signs and symptoms, limited laboratory testing and technologies that are inaccessible, unaffordable or unsuitable for resource-constrained settings. There is…

Medicine (4 works) · Bacterial Identification and Susceptibility Testing (3 works) · Microbiology (3 works) · Neonatal and Maternal Infections (3 works) · Sepsis (3 works) · Antibiotics (2 works) · Biology (2 works) · Diagnostic test (2 works) · Internal Medicine (2 works) · Neonatal sepsis (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae